RA news

  • Biosimilars and Rheumatoid Arthritis | Making the switch

    23 Mar 2018

    The Oxford Academic Health Science Network (Oxford AHSN) and Sandoz, have developed an informative animation on biosimilars with input from individuals living with inflammatory arthritis and in partnership with the National Rheumatoid Arthritis Society.

  • NRAS welcomes review of PIP assessments

    2 Feb 2018

    Earlier this week, the Department for Work and Pensions (DWP) announced that every person receiving Personal Independence Payments (PIP) will have their claim reviewed. This follows a court ruling that said changes to PIP were unfair to people with mental health conditions.

  • Looking after yourself this flu season

    26 Jan 2018

    Getting an annual flu vaccine is recommended for people with RA, but if you do develop flu or live with someone who has it, the following advice issued to patients by Portsmouth Hospital’s Department of Rheumatology may be useful to you.

  • CIMZIA® label change marks an important advance for women in the UK of childbearing age with moderate to severe active rheumatoid arthritis

    15 Jan 2018

    The European Medicines Agency (EMA) has approved the label change for UCB’s CIMZIA® (certolizumab pegol), making it the first anti-TNF for potential use in women with moderate to severe active rheumatoid arthritis, active psoriatic arthritis and ankylosing spondylitis during both pregnancy and breastfeeding.